ANI Pharmaceuticals
ANIP
ANIP
230 hedge funds and large institutions have $1.29B invested in ANI Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 90 increasing their positions, 74 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.74% less ownership
Funds ownership: 91.84% → 91.1% (-0.74%)
5% less capital invested
Capital invested by funds: $1.35B → $1.29B (-$62.3M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
230
Holding in Top 10
2
Calls
$1.37M
Puts
$874K
Top Buyers
| 1 | +$21M | |
| 2 | +$13.1M | |
| 3 | +$12.5M | |
| 4 |
Millennium Management
New York
|
+$12.1M |
| 5 |
Teacher Retirement System of Texas
Austin,
Texas
|
+$9.32M |
Top Sellers
| 1 | -$27.8M | |
| 2 | -$15.4M | |
| 3 | -$11.3M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$11.3M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$11.1M |
